TORONTO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Toronto based CO2 GRO Inc. (“GROW” or the “Company”) (TSX-V: GROW) is pleased to announce another positive commercial indoor cannabis grow trial. The second trial was on a leafier indica strain that yielded an estimated 60% increase in bud value whereas the first trial on a stringier sativa strain yielded an estimated 45%.
Read more
CO2 GRO’s Second Cannabis Trial Yields a 60% Increase In Bud Value and a 75% Increase In THC
